ANDREA GIBSON: Open Payments
NPI 1063113488 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 33 payments from 15 companies in 2025. Trend: 2023 $151 · 2024 $616 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $100 |
| Astellas Pharma US Inc | 4 | $98 |
| ABBVIE INC. | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Exact Sciences Corporation | 3 | $43 |
| Lilly USA, LLC | 2 | $32 |
| Amgen Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: Veozah, JARDIANCE, Wegovy, Cologuard Collection Kit, QULIPTA, SHINGRIX, EVENITY, Kerendia.
Industry payments across GA — which companies pay providers there.
